Chao Wang
Impact in
- Biomaterials top 0.02%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 0.01%
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
- Immunology 87
- Immunotherapy and Immune Responses 51
- Immune cells in cancer 24
-
- Nanoplatforms for cancer theranostics 116
- Co-authors
- Zhuang Liu (85 shared papers)Liang Cheng (33 shared papers)Zhen Nan Gu (39 shared papers)Quanyin Hu (22 shared papers)Liangzhu Feng (7 shared papers)Chao Liang (17 shared papers)Qian Chen (20 shared papers)Wujin Sun (20 shared papers)
- Journals
- Advanced Materials (30 papers)Biomaterials (19 papers)Advanced Functional Materials (14 papers)ACS Nano (14 papers)Journal of Controlled Release (11 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Chao Wang
370 papers receiving 39.9k citations
Chao Wang's Hit Papers
Peers
Comparison fields: 5 of 180
- Biomaterials 9.0k
- Biomedical Engineering 24.4k
- Immunology 6.6k
- Pharmaceutical Science 1.6k
- Materials Chemistry 12.7k
Countries citing papers authored by Chao Wang
This map shows the geographic impact of Chao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao Wang more than expected).
Fields of papers citing papers by Chao Wang
This network shows the impact of papers produced by Chao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao Wang. The network helps show where Chao Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Chao Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 381 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Functional Nanomaterials for Phototherapies of Cancer Hit paper breakdown → | 2014 | 2289 |
| 2 | Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy Hit paper breakdown → | 2016 | 1482 |
| 3 | Drug Delivery with PEGylated MoS 2 Nano‐sheets for Combined Photothermal and Chemotherapy of Cancer Hit paper breakdown → | 2014 | 1139 |
| 4 | PEGylated WS2 Nanosheets as a Multifunctional Theranostic Agent for in vivo Dual‐Modal CT/Photoacoustic Imaging Guided Photothermal Therapy Hit paper breakdown → | 2013 | 1059 |
| 5 | Photothermally Enhanced Photodynamic Therapy Delivered by Nano-Graphene Oxide Hit paper breakdown → | 2011 | 1007 |
| 6 | In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment Hit paper breakdown → | 2018 | 925 |
| 7 | Facile Preparation of Multifunctional Upconversion Nanoprobes for Multimodal Imaging and Dual‐Targeted Photothermal Therapy Hit paper breakdown → | 2011 | 805 |
| 8 | Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles Hit paper breakdown → | 2011 | 753 |
| 9 | ROS-scavenging hydrogel to promote healing of bacteria infected diabetic wounds Hit paper breakdown → | 2020 | 744 |
| 10 | Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody Hit paper breakdown → | 2016 | 713 |
| 11 | Self‐Assembled DNA Nanoclews for the Efficient Delivery of CRISPR–Cas9 for Genome Editing Hit paper breakdown → | 2015 | 695 |
| 12 | Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy Hit paper breakdown → | 2010 | 609 |
| 13 | Anticancer Platelet‐Mimicking Nanovehicles Hit paper breakdown → | 2015 | 584 |
| 14 | Erythrocyte‐Membrane‐Enveloped Perfluorocarbon as Nanoscale Artificial Red Blood Cells to Relieve Tumor Hypoxia and Enhance Cancer Radiotherapy Hit paper breakdown → | 2017 | 563 |
| 15 | Recent advances of cocktail chemotherapy by combination drug delivery systems Hit paper breakdown → | 2015 | 554 |
| 16 | In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy Hit paper breakdown → | 2018 | 549 |
| 17 | Transformable liquid-metal nanomedicine Hit paper breakdown → | 2015 | 538 |
| 18 | In Vitro and In Vivo Uncaging and Bioluminescence Imaging by Using Photocaged Upconversion Nanoparticles Hit paper breakdown → | 2012 | 523 |
| 19 | Immunological Responses Triggered by Photothermal Therapy with Carbon Nanotubes in Combination with Anti‐CTLA‐4 Therapy to Inhibit Cancer Metastasis Hit paper breakdown → | 2014 | 515 |
| 20 | A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy Hit paper breakdown → | 2020 | 498 |
About Chao Wang
Chao Wang is a scholar working on Immunology, Biomedical Engineering, Biomaterials, Oncology and Molecular Biology, having authored 381 papers that have together received 41.0k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (116 papers), Immunotherapy and Immune Responses (51 papers), Nanoparticle-Based Drug Delivery (40 papers), Extracellular vesicles in disease (37 papers), Cancer Immunotherapy and Biomarkers (31 papers), CAR-T cell therapy research (24 papers), Immune cells in cancer (24 papers) and RNA Interference and Gene Delivery (22 papers). The work is most often cited by research in Biomaterials (9.0k citations), Biomedical Engineering (24.4k citations), Immunology (6.6k citations), Pharmaceutical Science (1.6k citations) and Materials Chemistry (12.7k citations). Chao Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Zhuang Liu, Liang Cheng, Zhen Nan Gu, Quanyin Hu, Liangzhu Feng, Chao Liang, Qian Chen, Wujin Sun, Kai Yang and Yanqi Ye. Their work appears in journals such as Advanced Materials, Biomaterials, Advanced Functional Materials, ACS Nano and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.